Tonix (TNXP) news
Recent news
Monkeypox stocks rose in regular trading, with TNXP up 6.8%, GILD gaining 2.5% and VTRS rising 1.9%.
On October 14, 2026, shares of companies associated with monkeypox treatments and vaccines rose in regular trading. Tonix Pharmaceuticals Holding Corp (TNXP) gained 6.8%, while Gilead Sciences (GILD) rose 2.5%, and Verrica Pharmaceuticals (VTRS) increased by 1.9%. The uptick in stock prices…
AInvest Wire · 13h agoMonkeypox stocks fell in intraday trading, with INO down 9.0%, TNXP falling 3.5% and VRAX sliding 2.7%.
AInvest Wire · 1d agoFreshworks Inc: Freshworks to extend FreshService into AI, software spend governance with pact to buy Torii
AInvest Wire · 2d agoTonix Pharmaceuticals: Co intends to enforce Tonmya intellectual property rights - SEC filing
AInvest Wire · Oct 2, 2026Tonix Pharmaceuticals: Paragraph IV certification challenges four Tonmya patents listed in FDA Orange Book - SEC filing
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) faces legal challenges as a generic drug manufacturer files a Paragraph IV certification challenging four patents listed in the FDA Orange Book for Tonmya, the company’s FDA-approved treatment for major depressive disorder. The certification,…
AInvest Wire · Oct 2, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.